NO20001196L - Nootropisk middel - Google Patents
Nootropisk middelInfo
- Publication number
- NO20001196L NO20001196L NO20001196A NO20001196A NO20001196L NO 20001196 L NO20001196 L NO 20001196L NO 20001196 A NO20001196 A NO 20001196A NO 20001196 A NO20001196 A NO 20001196A NO 20001196 L NO20001196 L NO 20001196L
- Authority
- NO
- Norway
- Prior art keywords
- long
- activation
- cerebral
- term activation
- nootropic agent
- Prior art date
Links
- 239000002664 nootropic agent Substances 0.000 title abstract 2
- 230000004913 activation Effects 0.000 abstract 3
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 230000007774 longterm Effects 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 102000003923 Protein Kinase C Human genes 0.000 abstract 1
- 108090000315 Protein Kinase C Proteins 0.000 abstract 1
- 206010042364 Subdural haemorrhage Diseases 0.000 abstract 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004373 acetylcholine Drugs 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229930195712 glutamate Natural products 0.000 abstract 1
- 208000003906 hydrocephalus Diseases 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 230000003518 presynaptic effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000005062 synaptic transmission Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9249131A JPH1180027A (ja) | 1997-09-12 | 1997-09-12 | 向知性薬 |
| PCT/JP1998/004136 WO1999013911A1 (fr) | 1997-09-12 | 1998-09-14 | Agent nootrope |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001196D0 NO20001196D0 (no) | 2000-03-08 |
| NO20001196L true NO20001196L (no) | 2000-05-10 |
Family
ID=17188397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001196A NO20001196L (no) | 1997-09-12 | 2000-03-08 | Nootropisk middel |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1022029A1 (fr) |
| JP (1) | JPH1180027A (fr) |
| KR (1) | KR20010030582A (fr) |
| CN (1) | CN1270528A (fr) |
| AU (1) | AU9003598A (fr) |
| BR (1) | BR9815370A (fr) |
| CA (1) | CA2301782A1 (fr) |
| ID (1) | ID24282A (fr) |
| IL (1) | IL134661A0 (fr) |
| NO (1) | NO20001196L (fr) |
| WO (1) | WO1999013911A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW544311B (en) * | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
| CA2374921A1 (fr) * | 1999-05-31 | 2000-12-07 | Shigeo Watabe | Inhibiteurs de la mort neuronale |
| US6423739B1 (en) | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| US6348489B1 (en) * | 2000-04-11 | 2002-02-19 | Daiichi Pharmaceutical Co., Ltd. | Method of treating traumatic brain injury and other neuronal disorders |
| GB0021885D0 (en) * | 2000-09-06 | 2000-10-18 | Fujisawa Pharmaceutical Co | New use |
| JP2005501108A (ja) * | 2001-08-22 | 2005-01-13 | 第一製薬株式会社 | 神経変性治療におけるネフィラセタムの使用 |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| PL2540297T3 (pl) | 2008-11-19 | 2015-12-31 | Forum Pharmaceuticals Inc | Leczenie zaburzeń funkcji poznawczych(R)-7-chloro-N-(chinuklidyn-3-ylo)benzo[b]tiofeno-2-karboksyamidem i jego farmaceutyczne dopuszczalnymi solami |
| KR101698250B1 (ko) | 2010-05-17 | 2017-01-19 | 포럼 파마슈티칼즈 인크. | (R)-7-클로로-N-(퀴누클리딘-3-일)벤조[b]티오펜-2-카르복사미드 히드로클로리드 모노히드레이트의 결정질 형태 |
| RU2635522C2 (ru) | 2012-05-08 | 2017-11-13 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
| JP6066312B2 (ja) * | 2013-03-29 | 2017-01-25 | 国立研究開発法人理化学研究所 | 細胞膜片を備えた発電素子および発電デバイス |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3388778B2 (ja) * | 1991-05-02 | 2003-03-24 | 第一製薬株式会社 | 脳血管性痴呆改善剤 |
| ZA923134B (en) * | 1991-05-02 | 1993-01-27 | Daiichi Seiyaku Co | Agent for improving dementia |
| JPH06279311A (ja) * | 1993-03-26 | 1994-10-04 | Sagami Chem Res Center | プロテインキナーゼｃアイソザイムの活性化剤 |
-
1997
- 1997-09-12 JP JP9249131A patent/JPH1180027A/ja active Pending
-
1998
- 1998-09-14 KR KR1020007002597A patent/KR20010030582A/ko not_active Ceased
- 1998-09-14 ID IDW20000459A patent/ID24282A/id unknown
- 1998-09-14 WO PCT/JP1998/004136 patent/WO1999013911A1/fr not_active Ceased
- 1998-09-14 AU AU90035/98A patent/AU9003598A/en not_active Abandoned
- 1998-09-14 CN CN98809035A patent/CN1270528A/zh active Pending
- 1998-09-14 EP EP98941864A patent/EP1022029A1/fr not_active Withdrawn
- 1998-09-14 BR BR9815370-6A patent/BR9815370A/pt not_active IP Right Cessation
- 1998-09-14 IL IL13466198A patent/IL134661A0/xx unknown
- 1998-09-14 CA CA002301782A patent/CA2301782A1/fr not_active Abandoned
-
2000
- 2000-03-08 NO NO20001196A patent/NO20001196L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH1180027A (ja) | 1999-03-23 |
| NO20001196D0 (no) | 2000-03-08 |
| KR20010030582A (ko) | 2001-04-16 |
| BR9815370A (pt) | 2000-10-24 |
| EP1022029A1 (fr) | 2000-07-26 |
| CN1270528A (zh) | 2000-10-18 |
| WO1999013911A1 (fr) | 1999-03-25 |
| AU9003598A (en) | 1999-04-05 |
| IL134661A0 (en) | 2001-04-30 |
| ID24282A (id) | 2000-07-13 |
| CA2301782A1 (fr) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001196L (no) | Nootropisk middel | |
| ATE203019T1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane | |
| ATE108668T1 (de) | Transdermale applikation von 2-amino-6-n- propylamino-4,5,6,7-tetrahydrobenzothiazol. | |
| MA26548A1 (fr) | Compositions pharmaceutiques topiques contenant des derives de resorcinol. | |
| ATE234092T1 (de) | 2-alkylpyrrolidine | |
| DK0807111T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse | |
| NO170333C (no) | Benzotriazoler med herbicid virkning, herbicid middel og anvendelse av forbindelsene som herbicider | |
| TR199801930T2 (xx) | 6-Fenilpiridil-2-amin t�revleri. | |
| NO20010446L (no) | Substituert anilidforbindelser og metoder | |
| DK0740650T3 (da) | Codrugs som metode til styret transport af lægemiddel | |
| NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
| DK0751939T5 (da) | Naphthylamider som centralnervesystemmidler | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
| EE200100179A (et) | Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks | |
| DK0825857T3 (da) | Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse | |
| DK0520200T3 (da) | Imadazol-forbindelser, deres fremstilling og anvendelse | |
| NO20006646L (no) | Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel | |
| DK0636027T3 (da) | Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati | |
| NO20005332L (no) | 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding | |
| DK0914043T3 (da) | Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf | |
| DE69705110D1 (de) | Topische pharmazeutische zusammensetzungen, welche heparin enthalten | |
| RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
| WO2001085165A3 (fr) | Combinaison d'acide lipoique et de donneurs d'unites c1 pour le traitement de troubles du systeme nerveux central | |
| IT1288494B1 (it) | Metodo e dispositivo per il controllo senza contatto diretto delle teste delle sigarette, o simili. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |